Liddle C - Search Results

1

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.

Wong M, Balleine RL, Collins M, Liddle C, Clarke CL, Gurney H. Wong M, et al. Among authors: liddle c. Clin Pharmacol Ther. 2004 Jun;75(6):529-38. doi: 10.1016/j.clpt.2004.02.005. Clin Pharmacol Ther. 2004. PMID: 15179407

2

Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.

Fox P, Balleine RL, Lee C, Gao B, Balakrishnar B, Menzies AM, Yeap SH, Ali SS, Gebski V, Provan P, Coulter S, Liddle C, Hui R, Kefford R, Lynch J, Wong M, Wilcken N, Gurney H. Fox P, et al. Among authors: liddle c. Clin Cancer Res. 2016 Jul 1;22(13):3164-71. doi: 10.1158/1078-0432.CCR-15-1470. Epub 2016 Feb 4. Clin Cancer Res. 2016. PMID: 26847054 Clinical Trial.

3

Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?

Lee CI, Fox P, Balakrishnar B, Balleine RL, Gao B, Provan P, Coulter S, Liddle C, Hui R, Wong M, Gurney H, Wilcken N. Lee CI, et al. Among authors: liddle c. Breast. 2019 Aug;46:52-57. doi: 10.1016/j.breast.2019.05.009. Epub 2019 May 6. Breast. 2019. PMID: 31082762

4

Transporter pumps and imatinib: a cause of pharmacokinetic resistance?

Klumpen HJ, Liddle C, Gurney H. Klumpen HJ, et al. Among authors: liddle c. Cancer Biol Ther. 2008 Mar;7(3):416-8. doi: 10.4161/cbt.7.3.5840. Epub 2008 Mar 3. Cancer Biol Ther. 2008. PMID: 18334863 Free article. No abstract available.

5

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio.

Lee CI, Low SK, Maldonado R, Fox P, Balakrishnar B, Coulter S, de Bruijn P, Koolen SLW, Gao B, Lynch J, Zdenkowski N, Hui R, Liddle C, Mathijssen RHJ, Wilcken N, Wong M, Gurney H. Lee CI, et al. Among authors: liddle c. Breast. 2020 Dec;54:229-234. doi: 10.1016/j.breast.2020.10.008. Epub 2020 Oct 21. Breast. 2020. PMID: 33161337 Free PMC article.

6

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring.

Sabanathan D, Zhang A, Fox P, Coulter S, Gebski V, Balakrishnar B, Chan M, Liddle C, Gurney H. Sabanathan D, et al. Among authors: liddle c. Cancer Chemother Pharmacol. 2017 Aug;80(2):385-393. doi: 10.1007/s00280-017-3362-1. Epub 2017 Jun 30. Cancer Chemother Pharmacol. 2017. PMID: 28667354

7

Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysis.

Khushi M, Liddle C, Clarke CL, Graham JD. Khushi M, et al. Among authors: liddle c. PLoS One. 2014 Feb 12;9(2):e87301. doi: 10.1371/journal.pone.0087301. eCollection 2014. PLoS One. 2014. PMID: 24533055 Free PMC article.

8

Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice.

Robertson GR, Liddle C, Clarke SJ. Robertson GR, et al. Among authors: liddle c. Clin Pharmacol Ther. 2008 Jun;83(6):894-7. doi: 10.1038/clpt.2008.55. Epub 2008 Mar 26. Clin Pharmacol Ther. 2008. PMID: 18388870 Review.

9

Transgenic mouse models of human CYP3A4 gene regulation.

Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C. Robertson GR, et al. Among authors: liddle c. Mol Pharmacol. 2003 Jul;64(1):42-50. doi: 10.1124/mol.64.1.42. Mol Pharmacol. 2003. PMID: 12815159

10

The mechanism of cyclosporine toxicity induced by clarithromycin.

Spicer ST, Liddle C, Chapman JR, Barclay P, Nankivell BJ, Thomas P, O'Connell PJ. Spicer ST, et al. Among authors: liddle c. Br J Clin Pharmacol. 1997 Feb;43(2):194-6. doi: 10.1046/j.1365-2125.1997.54310.x. Br J Clin Pharmacol. 1997. PMID: 9131953 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters